Search
for
Sort by
Research 61–90 of 1000+
- Claims for the cost of care: local authority provision
- P35: Facility Cost Analysis in Outpatient Plastic Surgery: Implications for Aesthetic Surgery in the Academic Health Center
- Analysis of Cost-effectiveness of 4 Kinds of Projects for Drug Therapy in the Treatment of BPH
- A spy on costal plant-Mangrove: A review article
- Minoxidil, Platelet-Rich Plasma (PRP), or Combined Minoxidil and PRP for Androgenetic Alopecia in Men: A Cost-Effectiveness Markov Decision Analysis of Prospective Studies
- Association Between Gender and Drug Cost for Over-the-Counter Minoxidil
- Cult of the Body Beautiful: At What Cost?
- The pink tax: gender-based cost disparities of topical minoxidil
- P46 A rare case of costovertebral arthritis in SLE
- iPrimer-seq: A Streamlined and Cost-Effective Early-Barcoding 3'-End Rna-Seq Method for Transcriptome Profiling from Limiting Cell Inputs
- Niosomal <i>versus</i> cubosomal gels of cetirizine hydrochloride: Cost-effective permeation enhancement for potential transdermal application
- Direct-to-consumer Androgenetic Alopecia treatments: A Cost Comparison with traditional pharmacies
- 1455 Cutaneous wounds healed at the cost of overall fitness in the aged Balb/C mouse model
- A high price toupee: The costs of baldness in Por los pelos
- Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model
- Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data
- Logistics Service Quality, Logistics Cost, and Customs Clearance on Delivery Service Loyalty in the Indonesian Holtikura Industry
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Response to Ong et al., "Hair-raising costs: evaluating botulinum toxin treatment for androgenetic alopecia."
- Alternative and Complimentary Medicines in the management of Chronic Breast Cancer: A discrete choice cost and clinical case report
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?
- Clinical Diagnosis of COVID-19: a Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1,757-Patient Cohort (The AndroCoV Clinical Scoring for COVID-19 Diagnosis).
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Clinical-Exome Sequencing Unveils the Genetic Landscape of Polycystic Ovarian Syndrome (PCOS) Focusing on Lean and Obese Phenotypes: Implications for Cost-Effective Diagnosis and Personalized Treatment
- Influence of Clinical and Sociodemographic Factors on the Management, Costs, and Outcomes of Acute Urinary Retention in the Acute Care Setting
- Follicular Transplantation, Microneedling, and Adjuvant Narrow-band Ultraviolet-B Irradiation as Cost-Effective Regimens for Palmar-Plantar Vitiligo: A Pilot Study
- Can You Really Have Too Much of a Good Thing?: How Benevolent Tax Policies Have Attributed to the Explosion of Health Care Costs and How New Policies Threaten to Do More of the Same
- Weakly supervised learning of biomedical information extraction from curated data